Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

Source: BMC Cancer - Category: Cancer & Oncology Authors: Tags: Correction Source Type: research